Clinical use of high sensitivity C-reactive protein for the prediction of adverse cardiovascular events

被引：115

作者：

Torres, JL ^{[1
]}

Ridker, PM ^{[1
]}

机构：

[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Boston, MA 02215 USA

来源：

CURRENT OPINION IN CARDIOLOGY | 2003年 / 18卷 / 06期

关键词：

C-reactive protein; inflammation; myocardial infarction; prevention; statins; aspirin;

D O I：

10.1097/00001573-200311000-00008

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

High-sensitivity C-reactive protein evaluation has recently been endorsed by the Centers for Disease Control and Prevention and by the American Heart Association to be used in conjunction with lipid evaluation as part of global risk prediction. Emerging evidence further suggests that high-sensitivity C-reactive protein can be used to target pharmacologic and lifestyle interventions designed to prevent first as well as recurrent cardiovascular events.

引用

页码：471 / 478

页数：8

共 59 条

[1] LEUKOCYTE-ENDOTHELIAL INTERACTIONS AND REGULATION OF LEUKOCYTE MIGRATION [J].

ADAMS, DH ;

SHAW, S .

LANCET, 1994, 343 (8901) :831-836

[2] Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death [J].

Albert, CM ;

Ma, J ;

Rifai, N ;

Stampfer, MJ ;

Ridker, PM .

CIRCULATION, 2002, 105 (22) :2595-2599

[3] Effect of statin therapy on C-reactive protein levels - The Pravastatin Inflammation/CRP Evaluation (PRINCE): A randomized trial and cohort study [J].

Albert, MA ;

Danielson, E ;

Rifai, N ;

Ridker, PM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (01) :64-70

[4] Plasma concentration of C-reactive protein and the calculated Framingham Coronary Heart Disease Risk Score [J].

Albert, MA ;

Glynn, RJ ;

Ridker, PM .

CIRCULATION, 2003, 108 (02) :161-165

[5] CYTOKINES AND GROWTH-FACTORS POSITIVELY AND NEGATIVELY REGULATE INTERSTITIAL COLLAGEN GENE-EXPRESSION IN HUMAN VASCULAR SMOOTH-MUSCLE CELLS [J].

AMENTO, EP ;

EHSANI, N ;

PALMER, H ;

LIBBY, P .

ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (05) :1223-1230

[6]

[Anonymous], KIDNEY INT S

[7] Inflammatory bio-markers and cardiovascular risk prediction [J].

Blake, GJ ;

Ridker, PM .

JOURNAL OF INTERNAL MEDICINE, 2002, 252 (04) :283-294

[8] Novel clinical markers of vascular wall inflammation [J].

Blake, GJ ;

Ridker, PM .

CIRCULATION RESEARCH, 2001, 89 (09) :763-771

[9] Changes in platelet P-selectin and in plasma C-reactive protein in acute atherosclerotic ischemic stroke treated with a loading dose of clopidogrel [J].

Cha, JK ;

Jeong, MH ;

Lee, KM ;

Bae, HR ;

Lim, YJ ;

Park, KW ;

Cheon, SM .

JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2002, 14 (02) :145-150

[10] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].

Cleeman, JI ;

Grundy, SM ;

Becker, D ;

Clark, LT ;

Cooper, RS ;

Denke, MA ;

Howard, WJ ;

Hunninghake, DB ;

Illingworth, DR ;

Luepker, RV ;

McBride, P ;

McKenney, JM ;

Pasternak, RC ;

Stone, NJ ;

Van Horn, L ;

Brewer, HB ;

Ernst, ND ;

Gordon, D ;

Levy, D ;

Rifkind, B ;

Rossouw, JE ;

Savage, P ;

Haffner, SM ;

Orloff, DG ;

Proschan, MA ;

Schwartz, JS ;

Sempos, CT ;

Shero, ST ;

Murray, EZ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497

← 1 2 3 4 5 6 →